The preparation of carbon-14 and tritium radio-labeled PD-72953

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 50, Issue 5-6, 2007, Pages 602-604

  Zhang, Yinsheng ^a,d   Jian, Zhigang ^b   Hong, Yang ^c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Pharmaceutical Research Institute   (United States)

^d PFIZER INC   (United States)

Author keywords

Alkylation; Carbon 14; Palladium; Radioactive isotope; Reduction; Tritium

Indexed keywords

CARBON; TRITIUM;

% REDUCTIONS; CARBON 14;

PALLADIUM;

4 CHLOROBUTYL ETHER; CARBON 14; ETHER DERIVATIVE; ISOBUTYRIC ACID; PALLADIUM; PD 72953; RADIOPHARMACEUTICAL AGENT; TRITIUM; UNCLASSIFIED DRUG;

ALKYLATION; CONFERENCE PAPER; DRUG DESIGN; DRUG SYNTHESIS; ISOTOPE LABELING;

EID: 34548167526     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1298     Document Type: Conference Paper

References (2)

1. Bisgaier CL, Essenburg AD, Barnett BC. J Lipid Res 1998; 39(1): 17-30.
2. Gleiter R, Rittinger S, Langer H. Chem Ber 1991; 124(2): 357-363.